[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioaffinity Technologies Inc (BIAF)

Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,971
  • Shares Outstanding, K 4,743
  • Annual Sales, $ 6,160 K
  • Annual Income, $ -14,910 K
  • EBIT $ -11 M
  • EBITDA $ -11 M
  • 60-Month Beta -1.33
  • Price/Sales 0.64
  • Price/Cash Flow N/A
  • Price/Book 1.03
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -8.52
  • Most Recent Earnings $-0.81 on 05/08/26
  • Next Earnings Date 08/13/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8000 +1.25%
on 06/17/26
2.1750 -62.76%
on 06/02/26
-0.7500 (-48.08%)
since 05/22/26
3-Month
0.8000 +1.25%
on 06/17/26
5.3800 -84.94%
on 03/23/26
-1.9200 (-70.33%)
since 03/20/26
52-Week
0.6930 +16.88%
on 02/05/26
13.8000 -94.13%
on 06/26/25
-6.2820 (-88.58%)
since 06/20/25

Most Recent Stories

More News
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

Research suggests a potential topical treatment for common skin cancers, squamous cell and basal cell carcinoma Findings will be presented at 2026 RNA...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)
bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)
bioAffinity Technologies Announces Pricing of $3.2 Million Offering

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)
bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

Expert panel will share real-world case studies to demonstrate how mobile CT screening, noninvasive CyPath® Lung testing, and comprehensive functional lung imaging can reduce cost while improving access,...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)
Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar

Interventional pulmonologist, medical oncologist and thoracic surgeon will discuss how CyPath® Lung results have made a critical difference in their practices ...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)
bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology

Strong intellectual property portfolio helps build shareholder value Patent strategy protects CyPath ® Lung’s flow...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)
bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026

CyPath ® Lung unit sales in April increased nearly 300% compared to April 2025 Increasing unit sales for CyPath ® ...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)
bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung

CyPath® Lung cancer diagnostic unit sales rise 146% year-over-year Growth expected to accelerate throughout 2026 as planned commercial initiatives seek...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)
bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment

Collaboration with nation’s largest military medical center focuses on bioAffinity Technologies’ pipeline of solutions to address debilitating respiratory diseases ...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy

Standard-of-care imaging and risk models indicated cancer after lung screening revealed 30-millimeter pulmonary nodule CyPath® Lung test affirmed physician’s...

BIAF : 0.8100 (-3.25%)
BIAFW : 0.1402 (-10.47%)

Business Summary

bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.

See More

Key Turning Points

3rd Resistance Point 0.9295
2nd Resistance Point 0.8997
1st Resistance Point 0.8685
Last Price 0.8100
1st Support Level 0.8075
2nd Support Level 0.7777
3rd Support Level 0.7465

See More

52-Week High 13.8000
Fibonacci 61.8% 8.7931
Fibonacci 50% 7.2465
Fibonacci 38.2% 5.6999
Last Price 0.8100
52-Week Low 0.6930

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.